280 related articles for article (PubMed ID: 1853202)
1. Solution structures of beta peptide and its constituent fragments: relation to amyloid deposition.
Barrow CJ; Zagorski MG
Science; 1991 Jul; 253(5016):179-82. PubMed ID: 1853202
[TBL] [Abstract][Full Text] [Related]
2. Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra.
Barrow CJ; Yasuda A; Kenny PT; Zagorski MG
J Mol Biol; 1992 Jun; 225(4):1075-93. PubMed ID: 1613791
[TBL] [Abstract][Full Text] [Related]
3. NMR studies of amyloid beta-peptides: proton assignments, secondary structure, and mechanism of an alpha-helix----beta-sheet conversion for a homologous, 28-residue, N-terminal fragment.
Zagorski MG; Barrow CJ
Biochemistry; 1992 Jun; 31(24):5621-31. PubMed ID: 1610809
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer's disease: soluble oligomeric Abeta(1-40) peptide in membrane mimic environment from solution NMR and circular dichroism studies.
Mandal PK; Pettegrew JW
Neurochem Res; 2004 Dec; 29(12):2267-72. PubMed ID: 15672549
[TBL] [Abstract][Full Text] [Related]
5. Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer's disease.
Hilbich C; Kisters-Woike B; Reed J; Masters CL; Beyreuther K
J Mol Biol; 1991 Mar; 218(1):149-63. PubMed ID: 2002499
[TBL] [Abstract][Full Text] [Related]
6. Human and rodent Alzheimer beta-amyloid peptides acquire distinct conformations in membrane-mimicking solvents.
Otvos L; Szendrei GI; Lee VM; Mantsch HH
Eur J Biochem; 1993 Jan; 211(1-2):249-57. PubMed ID: 8425535
[TBL] [Abstract][Full Text] [Related]
7. Solution structures of micelle-bound amyloid beta-(1-40) and beta-(1-42) peptides of Alzheimer's disease.
Shao H; Jao S; Ma K; Zagorski MG
J Mol Biol; 1999 Jan; 285(2):755-73. PubMed ID: 9878442
[TBL] [Abstract][Full Text] [Related]
8. 1H NMR of A beta amyloid peptide congeners in water solution. Conformational changes correlate with plaque competence.
Lee JP; Stimson ER; Ghilardi JR; Mantyh PW; Lu YA; Felix AM; Llanos W; Behbin A; Cummings M; Van Criekinge M
Biochemistry; 1995 Apr; 34(15):5191-200. PubMed ID: 7711039
[TBL] [Abstract][Full Text] [Related]
9. Solution structure of the Alzheimer amyloid beta-peptide (1-42) in an apolar microenvironment. Similarity with a virus fusion domain.
Crescenzi O; Tomaselli S; Guerrini R; Salvadori S; D'Ursi AM; Temussi PA; Picone D
Eur J Biochem; 2002 Nov; 269(22):5642-8. PubMed ID: 12423364
[TBL] [Abstract][Full Text] [Related]
10. Bacterial inclusion bodies of Alzheimer's disease β-amyloid peptides can be employed to study native-like aggregation intermediate states.
Dasari M; Espargaro A; Sabate R; Lopez del Amo JM; Fink U; Grelle G; Bieschke J; Ventura S; Reif B
Chembiochem; 2011 Feb; 12(3):407-23. PubMed ID: 21290543
[TBL] [Abstract][Full Text] [Related]
11. The influence of the carboxyl terminus of the Alzheimer Abeta peptide on its conformation, aggregation, and neurotoxic properties.
Soreghan B; Pike C; Kayed R; Tian W; Milton S; Cotman C; Glabe CG
Neuromolecular Med; 2002; 1(1):81-94. PubMed ID: 12025818
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the structures of beta amyloid peptide (25-35) and substance P in trifluoroethanol/water solution.
Lee S; Suh YH; Kim S; Kim Y
J Biomol Struct Dyn; 1999 Oct; 17(2):381-91. PubMed ID: 10563586
[TBL] [Abstract][Full Text] [Related]
13. pH-dependent conformations of the amyloid beta(1-28) peptide fragment explored using molecular dynamics.
Kirshenbaum K; Daggett V
Biochemistry; 1995 Jun; 34(23):7629-39. PubMed ID: 7779809
[TBL] [Abstract][Full Text] [Related]
14. Prolines and amyloidogenicity in fragments of the Alzheimer's peptide beta/A4.
Wood SJ; Wetzel R; Martin JD; Hurle MR
Biochemistry; 1995 Jan; 34(3):724-30. PubMed ID: 7827029
[TBL] [Abstract][Full Text] [Related]
15. Nicotine inhibits amyloid formation by the beta-peptide.
Salomon AR; Marcinowski KJ; Friedland RP; Zagorski MG
Biochemistry; 1996 Oct; 35(42):13568-78. PubMed ID: 8885836
[TBL] [Abstract][Full Text] [Related]
16. Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs.
Burdick D; Soreghan B; Kwon M; Kosmoski J; Knauer M; Henschen A; Yates J; Cotman C; Glabe C
J Biol Chem; 1992 Jan; 267(1):546-54. PubMed ID: 1730616
[TBL] [Abstract][Full Text] [Related]
17. Is amyloid deposition in Alzheimer's disease preceded by an environment-induced double conformational transition?
Hollosi M; Otvos L; Kajtar J; Percel A; Lee VM
Pept Res; 1989; 2(1):109-13. PubMed ID: 2520747
[TBL] [Abstract][Full Text] [Related]
18. Molecular modeling of the amyloid-beta-peptide using the homology to a fragment of triosephosphate isomerase that forms amyloid in vitro.
Contreras CF; Canales MA; Alvarez A; De Ferrari GV; Inestrosa NC
Protein Eng; 1999 Nov; 12(11):959-66. PubMed ID: 10585501
[TBL] [Abstract][Full Text] [Related]
19. Conformational polymorphism of the amyloidogenic peptide homologous to residues 113-127 of the prion protein.
Satheeshkumar KS; Jayakumar R
Biophys J; 2003 Jul; 85(1):473-83. PubMed ID: 12829502
[TBL] [Abstract][Full Text] [Related]
20. Synthetic post-translationally modified human A beta peptide exhibits a markedly increased tendency to form beta-pleated sheets in vitro.
Fabian H; Szendrei GI; Mantsch HH; Greenberg BD; Otvös L
Eur J Biochem; 1994 May; 221(3):959-64. PubMed ID: 8181478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
